InSilicoTrials platform generates digital regulatory grade evidence using FDA-supported in silico methodologies. Simulation, predictive intelligence, and AI can be applied to the whole drug development lifecycle, from discovery, clinical trials to commercial strategies. InSilicoTrials platform supports diverse disease areas with cutting-edge models, synthetic patient simulations, and virtual patients while significantly cutting R&D time and costs.